Seba Nadeef

Seba Nadeef

Auto-generated profile, based on publicly available information

Seba Nadeef

Department of Translational Genomics Center for Genomic Medicine, King Faisal Specialist Hospital, and Research Center Riyadh Saudi Arabia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Cell Reports
Verified
Journal Article
Open access
BFBodor Fallatah
Bodor Fallatah
MSMuhammad Shuaib
Muhammad Shuaib
SASabir Adroub
Sabir Adroub
APAndreu Paytuví-Gallart
Andreu Paytuví-Gallart
FVFrancesco Della Valle
Francesco Della Valle
VOValerio Orlando
Valerio Orlando
The role of chromatin-associated RNAi components in the nucleus of mammalian cells and in particular in the context of developmental programs remains to be elucidated. Here, we investigate the function of nuclear Argonaute 1 (Ago1) in gene expression regulation during skeletal muscle differentiation. We show that Ago1 is required for activation of the myogenic program by supporting chromatin modification mediated by developmental enhancer activation. Mechanistically, we demonstrate that Ago1 directly controls global H3K27 acetylation (H3K27ac) by regulating enhancer RNA (eRNA)-CREB-binding protein (CBP) acetyltransferase interaction, a key step in enhancer-driven gene activation. In particular, we show that Ago1 is specifically required for myogenic differentiation 1 (MyoD) and downstream myogenic gene activation, whereas its depletion leads to failure of CBP acetyltransferase activation and blocking of the myogenic program. Our work establishes a role of the mammalian enhancer-associated RNAi component Ago1 in epigenome regulation and activation of developmental programs.

21 October 2024 in The EMBO Journal
Verified
Journal Article
Open access
PLPeng Liu
Peng Liu
SNSeba Nadeef
Seba Nadeef
MSMaged F Serag
Maged F Serag
APAndreu Paytuví-Gallart
Andreu Paytuví-Gallart
MAMaram Abadi
Maram Abadi
VOValerio Orlando
Valerio Orlando
Circadian rhythmicity of gene expression is a conserved feature of cell physiology. This involves fine-tuning between transcriptional and post-transcriptional mechanisms and strongly depends on the metabolic state of the cell. Together these processes guarantee an adaptive plasticity of tissue-specific genetic programs. However, it is unclear how the epigenome and RNA Pol II rhythmicity are integrated. Here we show that the PcG protein EZH1 has a gateway bridging function in postmitotic skeletal muscle cells. On the one hand, the circadian clock master regulator BMAL1 directly controls oscillatory behavior and periodic assembly of core components of the PRC2–EZH1 complex. On the other hand, EZH1 is essential for circadian gene expression at alternate Zeitgeber times, through stabilization of RNA Polymerase II preinitiation complexes, thereby controlling nascent transcription. Collectively, our data show that PRC2–EZH1 regulates circadian transcription both negatively and positively by modulating chromatin states and basal transcription complex stability.

17 June 2026 in Clinical Genetics
Verified
Journal Article
Closed access
AAAbdullah Aldalaan
Abdullah Aldalaan
SNSeba Nadeef
Seba Nadeef
EKEbtissal Khouj
Ebtissal Khouj
FAFayez Alahmadi
Fayez Alahmadi
BABayan Aljamal
Bayan Aljamal
FAFowzan S. Alkuraya
Fowzan S. Alkuraya

6 November 2025 in medRxiv
Verified
Preprint
Open access
PDF file
PBPritha Bisarad
Pritha Bisarad
YWYung-Chun Wang
Yung-Chun Wang
PSPeter Skidmore
Peter Skidmore
CGCarolina I. Galaz-Montoya
Carolina I. Galaz-Montoya
SLSara A. Lewis
Sara A. Lewis
HDHossein Darvish
Hossein Darvish
Cerebral palsy (CP) is a neurodevelopmental disorder of motor function, with genetic etiologies, particularly de novo variants, identified in approximately one-third of cases. The contribution of consanguinity – long-recognized as a CP risk factor – has remained undefined. Here, we report findings from 188 primarily consanguineous Middle Eastern families with CP and identified putative causative genes in nearly three-quarters. The majority demonstrated recessive inheritance, although multi-level consanguinity and multilocus pathogenic variants complicated Mendelian assortment analyses. We identified 110 known CP-associated genes – five with phenotypic expansions and three others exhibiting new recessive inheritance patterns – and 24 novel candidates. We characterized ten candidates as high-confidence based on independent replication and protein modeling. We experimentally validated a role for SUCO variants in CP and newly identified a role for mid-gestational migrating excitatory neurons in the disorder. These findings highlight new genes, pathways, and phenotypes that reveal striking genomic diversity in CP.